Latest Regulatory Approvals News

Siren Gold’s latest drilling at its Sams Creek Project in New Zealand confirms significant gold mineralisation outside the established Main Zone, highlighting promising expansion potential along the 7km Sams Creek Dyke.

Neurotech International has opened the first clinical site for its pivotal Phase 3 trial of NTI164, targeting core symptoms of Autism Spectrum Disorder in children. This milestone marks a key step toward potential regulatory approval and commercialisation.

Triangle Energy is set to spin out its Philippine oil and gas assets into a new ASX-listed company, Tetragon Energy, offering shareholders direct exposure to promising Asian resources.

European Resources Limited (ASX: ERE) has announced a $4.26 million renounceable entitlement offer to accelerate exploration and metallurgical work at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, providing shareholders with a strategic opportunity amid significant recent resource growth.

Far East Gold has obtained a crucial environmental approval from the Indonesian government, clearing the way for advanced exploration at its Idenburg Gold Project and setting the stage for accelerated development.

Rox Resources has approved the Final Investment Decision for its Youanmi Gold Project, fully funded and ready to begin construction targeting first gold pour by mid-2027.

New Frontier Minerals has secured technical approval for its Mining Lease Application at the Big One Copper Deposit, setting the stage for potential near-term copper production amid a tightening global copper market.

Klevo Rewards’ subsidiary Fly Wallet has secured approval to join the SWIFT network, marking a key step in expanding its digital payments and rewards platform across the Asia-Pacific region.

Kina Securities Limited has launched its inaugural unsecured subordinated bond issue worth PGK 235 million, offering a fixed 7.55% coupon over 10 years, marking a significant step in Papua New Guinea's capital markets.

Arovella Therapeutics has secured TGA confirmation to advance its Phase 1 trial of ALA-101 in Australia via the efficient Clinical Trial Notification pathway, following FDA clearance in the US.

Latitude Group Holdings is considering launching a new Capital Notes 2 offer, potentially allowing existing CN1 holders to reinvest. The offer will require applications through appointed Syndicate Brokers under updated regulatory rules.

NH3 Clean Energy has locked in a crucial 15-year water supply agreement with the Water Corporation of WA for its flagship WAH2 clean ammonia project, marking a key step towards its final investment decision.